HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra Muench Selected Research

ASTX029

10/2021ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK.
1/2021Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandra Muench Research Topics

Disease

2Neoplasms (Cancer)
10/2021 - 01/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022
1Melanoma (Melanoma, Malignant)
01/2018

Drug/Important Bio-Agent (IBA)

2ASTX029IBA
10/2021 - 01/2021
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
10/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
01/2018

Therapy/Procedure

1Hematopoietic Stem Cell Transplantation
01/2022